Video | Business Headlines | Internet | Science | Scientific Ethics | Technology | Search

 


Leprosy Target Reached

The World Health Organisation (WHO) announced this month that it has reached its overall target, set ten years ago, for the global ‘elimination’ of leprosy. Over 11 million patients have been cured in the past 15 years, and the number of cases throughput the world has decreased by 90%.

In a partnership with pharmaceutical company Novartis, the WHO has been able to guarantee patients’ access to high quality drugs. Novartis designed and tested two of the three drugs that are used in multi-drug therapy (MDT) used to treat leprosy. The combination of drugs is highly effective and stops the transmission of the disease, starting with the first dose. Treatment lasts for 6-12 months depending on the severity of the disease.

The majority of leprosy cases reported are in India, with full control of the disease eluding five other countries – Brazil, Madagascar, Mozambique, Myanmar and Nepal. Novartis, and the WHO, in conjunction with health services in these countries have committed to implementing programmes to reduce numbers in these areas.

Novartis has also committed to donating MDT, through the WHO to the end of 2005, which will cure between 2.5 and 2.8 million patients. The commitment will guarantee access to high quality drugs for all patients during this time.
ends

© Scoop Media

 
 
 
 
 
Business Headlines | Sci-Tech Headlines

 

Watch This Space: Mahia Rocket Lab Launch Site Officially Opened

Economic Development Minster Steven Joyce today opened New Zealand’s first orbital launch site, Rocket Lab Launch Complex 1, on the Mahia Peninsula on the North Island’s east coast. More>>

Earlier:

Marketing Rocks!
Ig Nobel Award Winners Assess The Personality Of Rocks

A Massey University marketing lecturer has received the 2016 Ig Nobel Prize for economics for a research project that asked university students to describe the “brand personalities” of three rocks. More>>

ALSO:

Nurofen Promotion: Reckitt Benckiser To Plead Guilty To Misleading Ads

Reckitt Benckiser (New Zealand) intends to plead guilty to charges of misleading consumers over the way it promoted a range of Nurofen products, the Commerce Commission says. More>>

ALSO:

Half A Billion Accounts, Including Xtra: Yahoo Confirms Huge Data Breach

The account information may have included names, email addresses, telephone numbers, dates of birth, hashed passwords (the vast majority with bcrypt) and, in some cases, encrypted or unencrypted security questions and answers. More>>

ALSO:

Rural Branches: Westpac To Close 19 Branches, ANZ Looks At 7

Westpac confirms it will close nineteen branches across the country; ANZ closes its Ngaruawahia branch and is consulting on plans to close six more branches; The bank workers union says many of its members are nervous about their futures and asking ... More>>

Interest Rates: RBNZ's Wheeler Keeps OCR At 2%

Reserve Bank governor Graeme Wheeler kept the official cash rate at 2 percent and said more easing will be needed to get inflation back within the target band. More>>

ALSO:

Get More From Scoop

 
 
 
 
 
 
 
 
 
Sci-Tech
Search Scoop  
 
 
Powered by Vodafone
NZ independent news